Allium Vegetables and Garlic Supplements do Not Reduce Risk of Colorectal Cancer, Based on Meta-analysis of Prospective Studies.
Sommaire de l'article
BACKGROUND & AIMS
Laboratory studies have provided evidence that allium vegetables and garlic supplements might protect against colorectal cancer (CRC), but epidemiologic studies have produced inconsistent findings.
METHODS
We conducted a meta-analysis of prospective studies evaluating the associations between allium vegetables, garlic supplements, and CRC risk. We pooled effect measures using fixed or random-effect models, assessing the highest vs the lowest intakes. We used a dose-response regression model to evaluate the relationship between allium vegetable intake and CRC risk.
RESULTS
Our analysis included 8 studies with 20 reports of the effects of allium vegetables (5458 patients with CRC and 7125067 person-years) and 5 studies with 11 reports of the effects of garlic supplements (2685 patients with CRC and 2304439 person-years). We found no association between higher intake of allium vegetables and CRC risk (relative risk [RR]=1.06; 95% confidence interval [CI], 0.96-1.17; P=.26). Intake of allium vegetables did not correspond to CRC risk (P for nonlinear=.24, P for linear=.20). In subgroup analysis, higher consumption of allium vegetables was marginally associated with increased risk of colon cancer among women (RR=1.23; 95% CI, 1.01-1.50; P=.05). Use of garlic supplements was significantly associated with an increased risk of CRC (RR=1.18; 95% CI, 1.02-1.36; P=.03).
CONCLUSION
In a meta-analysis, we found no evidence that higher intake of allium vegetables reduces risk for CRC. We observed that garlic supplements increase risk for CRC, but this finding requires external validation.